The high post-CRT LCR in our cohort was largely a reflection of post-CRT maintenance of TLC with a small, but insignificant, increase in CRP level, and it might therefore be indicative of strong anti-tumor immunity and a mild pro-inflammatory effect on the microenvironment. The gene discussed is CRP; the disease is neoplasm.